Integrity Alliance LLC. Boosts Stake in The Clorox Company $CLX

Integrity Alliance LLC. increased its position in shares of The Clorox Company (NYSE:CLX) by 359.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 8,759 shares of the company’s stock after acquiring an additional 6,854 shares during the quarter. Integrity Alliance LLC.’s holdings in Clorox were worth $883,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Center for Financial Planning Inc. acquired a new stake in Clorox during the third quarter worth about $25,000. Vermillion & White Wealth Management Group LLC acquired a new stake in Clorox during the third quarter worth about $25,000. Darwin Wealth Management LLC acquired a new stake in Clorox during the second quarter worth about $29,000. Vision Financial Markets LLC increased its position in shares of Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after acquiring an additional 200 shares during the last quarter. Finally, Ameriflex Group Inc. increased its position in shares of Clorox by 1,436.8% during the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after acquiring an additional 273 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is owned by corporate insiders.

Clorox Stock Performance

NYSE:CLX opened at $96.19 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The stock has a market cap of $11.63 billion, a PE ratio of 15.62, a price-to-earnings-growth ratio of 0.50 and a beta of 0.59. The firm’s fifty day simple moving average is $98.82 and its 200-day simple moving average is $105.92.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the company posted $1.45 EPS. The business’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts expect that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Royal Bank Of Canada dropped their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. The Goldman Sachs Group restated a “sell” rating and issued a $83.00 price objective on shares of Clorox in a report on Friday, May 1st. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. Wells Fargo & Company reduced their price target on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, May 18th. Finally, Jefferies Financial Group reduced their price target on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.